OptimizeRx (OPRX) Akcie Kurz
OptimizeRx Kurz
Tržby rostly o 47,5 % ročně za posledních 18 let na 109,43 Mil. USD. Zisk na akcii rostl o 17,4 % ročně za posledních 12 let. čistá marže společnosti OptimizeRx je nyní 4,7 %, nahoru z 0,6 % před několika lety. Medián cílové ceny analytiků je 11,00 USD, tedy nad aktuální cenu o 20,0 %. Z 12 analytiků jich 11 doporučuje nákup — celkový konsenzus je Koupit.
Cena akcie OptimizeRx
Tato data přes Eulerpool API
100 000 požadavků/měs. zdarma · bez karty
Obchodní model OptimizeRx a analýza akcií
Nejčastější otázky týkající se akcie OptimizeRx
Some of the main competitors of OPTIMIZERx Corp in the market include Updox, Allscripts Healthcare Solutions, and NextGen Healthcare.
The business model of OPTIMIZERx Corp is focused on providing software solutions and technology platforms to the healthcare industry. The company offers a comprehensive suite of services, including electronic prescribing for healthcare providers, patient engagement and adherence tools, as well as financial assistance programs for patients to help them access and afford medication. OPTIMIZERx Corp's innovative technology enables pharmaceutical manufacturers to effectively engage with healthcare professionals and patients, improving patient outcomes and reducing healthcare costs. With its unique offerings and solutions, OPTIMIZERx Corp aims to optimize the connection between patients, healthcare providers, and pharmaceutical companies in the healthcare ecosystem.
OPTIMIZERx Corp is primarily active in the healthcare and pharmaceutical industries.
OPTIMIZERx Corp is a renowned digital health company that specializes in providing software solutions to streamline the pharmaceutical industry. Founded in 2006, OPTIMIZERx has established itself as a leader in the field, offering innovative platforms to enhance patient engagement and adherence. With a focus on improving communication between healthcare providers, pharmaceutical companies, and patients, OPTIMIZERx's solutions enable physicians to deliver cost-effective and personalized care. The company has consistently grown its presence by incorporating cutting-edge technologies and strategic partnerships, ensuring it stays at the forefront of the industry. OPTIMIZERx Corp's commitment to improving patient outcomes has made it a trusted name in the digital health sector.
OPTIMIZERx Corp, a leading provider of digital health communication solutions, has achieved several significant milestones. The company experienced impressive revenue growth, surpassing $30 million in annual revenue in 2020. In addition, OPTIMIZERx Corp expanded its client base, forging partnerships with renowned pharmaceutical manufacturers, healthcare providers, and pharmacies. The company launched innovative solutions, such as its SampleRx platform, which allows patients to access cost-saving coupons and trial offers for prescription medications. OPTIMIZERx Corp also made strategic acquisitions, augmenting its capabilities and expanding its market reach. These milestones demonstrate the company's commitment to revolutionizing patient engagement and improving prescription affordability in the healthcare industry.
OPTIMIZERx Corp is primarily present in the United States.
Optimizerx Corp represents values of innovation, collaboration, and customer-centricity. With a strong corporate philosophy focused on improving patient access to life-saving therapies, Optimizerx Corp aims to enhance the healthcare ecosystem through its digital platform and strategic partnerships. Committed to delivering superior solutions and services, the company leverages cutting-edge technology and data-driven insights to empower patients, healthcare providers, and pharmaceutical manufacturers. Optimizerx Corp strives to optimize the healthcare experience, driving better outcomes, cost-savings, and improved patient adherence. As a trusted leader in the industry, Optimizerx Corp demonstrates a dedication to excellence, integrity, and creating value for its shareholders, healthcare partners, and the overall community.
Analytici aktuálně stanovují průměrnou cílovou cenu 10,25 USD pro akcii OptimizeRx (medián: 11,00 USD), tedy +11,8 % vůči poslední ceně. Konsensus vychází z 12 hodnocení analytiků.
12 analytiků aktuálně hodnotí akcii OptimizeRx: 11 doporučuje koupit, 1 držet a 0 prodat. Pro rok 2026 analytici očekávají u OptimizeRx tržby 96,23 Mil. USD a zisk na akcii 0,86 USD.
Při aktuálním kurzu se akcie OptimizeRx obchoduje za 8,19 EUR (9,17 USD).
Akcie OptimizeRx (OPRX) je kótována na 1 burzách, mimo jiné: NASDAQ (OPRX).
The OPTIMIZERx Corp is a leading provider of digital solutions to improve patient communication, adherence, and access to medications. The company is headquartered in Rochester, Michigan and works with numerous pharmaceutical manufacturers, insurers, and pharmacies to optimize healthcare. One of OPTIMIZERx's main products is the Sample Fulfillment System (SFS), a paperless system for ordering and delivering medication samples to doctors. Doctors can access a wide range of medications, order samples, and effectively treat their patients through the system. The SFS is easy to use and provides doctors with a convenient way to receive medications and care for patients. OPTIMIZERx also offers a variety of patient communication solutions to improve compliance and adherence. The OPTIMIZERx portal is an online portal that allows patients to order and manage medications, as well as receive information about their medications and their side effects. The portal is user-friendly and easy to navigate, allowing patients to securely access their medical information. Another important area of OPTIMIZERx is supporting patients with coupons and discounts on prescription medications. OPTIMIZERx offers discount programs for a variety of medications to help patients manage the high costs of their medications. Similarly, OPTIMIZERx offers various options to assist patients in applying for discounts and ensuring they receive the best offer. In addition, OPTIMIZERx also provides communication solutions for pharmacies to improve information exchange and collaboration between pharmacies and doctors. The OPTIMIZERx eCoupon system allows pharmacies to pass on discounts and coupons directly to patients. In summary, the OPTIMIZERx Corp offers a wide range of digital solutions to improve patient communication, increase adherence and compliance, and facilitate access to medications. The company works closely with pharmaceutical manufacturers and other healthcare providers to optimize healthcare and provide the best possible support for patients.
Tržby očekávané za OptimizeRx činí 96,23 Mil. USD. Tato hodnota je založena na aktuálních finančních údajích a odráží výkonnost společnosti.
Zisk očekávané za OptimizeRx činí 16,71 Mil. USD. Čistý zisk odráží ziskovost společnosti po odečtení všech nákladů.
Poměr ceny k zisku (P/E) OptimizeRx je aktuálně 10,63. Poměr P/E porovnává aktuální cenu akcie se ziskem na akcii a pomáhá investorům posoudit ocenění akcie OptimizeRx.
Poměr ceny k tržbám (P/S) OptimizeRx je aktuálně 1,85. Poměr P/S porovnává tržní kapitalizaci s ročními tržbami a slouží jako metrika ocenění akcie OptimizeRx.
Score kvality pro OptimizeRx je 5/10.
ISIN OptimizeRx je US68401U2042. ISIN (International Securities Identification Number) je celosvětově jedinečný identifikátor cenných papírů.
WKN OptimizeRx je A2JL4Z. WKN (Wertpapierkennnummer) je šestimístný německý identifikační kód cenného papíru.
Ticker OptimizeRx je OPRX. Symbol tickeru se používá k obchodování akcií OptimizeRx na burze.
OptimizeRx akcie
OptimizeRx Peer Group
OptimizeRx Ticker
OptimizeRx FIGI
Všechny fundamentální údaje o OptimizeRx v podrobné analýze
Naše analýzy akcií společnosti OptimizeRx zahrnují důležité finanční ukazatele jako obrat, zisk, P/E poměr, P/S poměr, EBIT, stejně jako informace o dividendách. Dále zkoumáme aspekty jako akcie, tržní kapitalizaci, dluhy, vlastní kapitál a závazky společnosti OptimizeRx. Pokud hledáte podrobnější informace o těchto tématech, nabízíme vám na našich podstránkách rozsáhlé analýzy: